Stay updated on VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page.

Latest updates to the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision from v3.4.1 to v3.4.2 is shown on the page. This appears to be a backend update with no observed changes to the study details or how users interact with the page.SummaryDifference0.0%

- Check20 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1; no changes were made to trial content, eligibility criteria, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary feature added. Minor textual updates include the label 'Last Update Submitted that Met QC Criteria', capitalization tweaks for 'No FEAR Act Data', and the Revision updated to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. No substantive changes were made to the study details or on-page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations are now presented under a single 'Locations' section with state subsections (California, Connecticut, Georgia, Maryland, New York) and a revision note of v3.3.3, replacing the previous state-specific location headings. The footer link to 'HHS Vulnerability Disclosure' has been removed.SummaryDifference0.6%

- Check92 days agoChange DetectedRevision label on the study page header updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page.